Viemed Healthcare, Inc. (VMD) Stock Score, Valuation & Financial Research
Viemed Healthcare, Inc. is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 54/100.
Quick answer for VMD
Viemed Healthcare, Inc. currently has a Wall Street Score of 54/100. The stored market price is $8.84. Its financial score is 31/100. Its valuation score is 83/100. These figures are a research snapshot, not a buy or sell recommendation.
What Viemed Healthcare, Inc. does
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive
VMD financial snapshot
- Wall Street Score:
- 54/100
- Current price:
- $8.84
- Market capitalization:
- $336.6M
- Revenue:
- $286.6M
- Net income:
- $14.9M
- Free cash flow:
- $11.9M
- Cash:
- $9.8M
- Total debt:
- $12.4M
- EPS:
- 0.38
- P/E ratio:
- 23.3x
- Financial score:
- 31/100
- Valuation score:
- 83/100
- Revenue score:
- 35/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $11.9M, showing positive cash generation.
- The balance sheet shows $9.8M of cash versus $12.4M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 83/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 31/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research VMD
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.